Point-of-care testing (POCT) may be defined as the rapid specific testing of bodily fluids at the bedside.

Owing to the relatively long turnaround time of conventional laboratory tests, and with the aim of reducing inappropriate transfusion, there is increasing interest in point-of-care coagulation testing (POCCT) which can provide results within minutes. In addition, the wide acceptance of the current cell-based model of coagulation has led to an emphasis on the pivotal role of platelets and particular interest in devices testing whole blood, rather than plasma used in laboratory-based tests. The latter include the prothrombin time (PT) and activated partial thromboplastin time (aPTT) which provide information on the first phase of coagulation up to fibrin formation. Conversely, viscoelastic POCCT devices produce information on all phases of coagulation, providing insight into interactions between the cellular and plasma components of whole blood and the activity of the fibrinolytic system; all of which are vital for successful haemostasis.
This report elaborates the market size, market characteristics, and market growth of the Point-Of-Care Coagulation Testing Devices industry, and breaks down according to the type, application, and consumption area of Point-Of-Care Coagulation Testing Devices. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Point-Of-Care Coagulation Testing Devices in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Point-Of-Care Coagulation Testing Devices market covered in Chapter 13:
F.Hoffmann-La Roche
Goldsite Diagnostics Inc
Diagon
Helena Point of Care
Abbott Laboratories
Alere
Siemens Healthcare
ILine Microsystems
Medtronic
Getein Biotech, Inc.
HemoSonics
TaiDoc Technology Corporation
Callegari Srl
Sysmex
CoaquSense
Accriva Diagnostics
Micropoint Bioscience

In Chapter 6, on the basis of types, the Point-Of-Care Coagulation Testing Devices market from 2015 to 2025 is primarily split into:
Diabete POC Analyzer
Coaglulation POC Analyzer
POC Blood Analyzer
Hematology POC Reader

In Chapter 7, on the basis of applications, the Point-Of-Care Coagulation Testing Devices market from 2015 to 2025 covers:
Retail Prices
Hospitals
Clinics
Health Centers
Homecare Settings

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025